COVID-19 Asked & Answered: Johnson & Johnson Vaccine

COVID-19 Asked & Answered: Johnson & Johnson Vaccine

The FDA has paused use of the J&J COVID-19 vaccine after six people—out of the almost 7 million people who so far have received the vaccine—developed a rare blood clotting disorder. Experts do not yet know if the J&J vaccine is responsible for the blood clots, so even though six events in the U.S. is very small, regulatory authorities are taking this time to assemble data on the occurrence of these types of clots in the general population and develop monitoring and treatment recommendations for clinicians and the public.